Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Lidco Group Plc LSE:LID London Ordinary Share GB0030546849 ORD 0.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.10p +2.00% 5.10p 5.00p 5.20p 5.10p 5.00p 5.00p 368,560 12:56:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 7.3 -2.1 -0.8 - 12.45

Lidco Share Discussion Threads

Showing 6551 to 6573 of 6575 messages
Chat Pages: 263  262  261  260  259  258  257  256  255  254  253  252  Older
DateSubjectAuthorDiscuss
19/5/2019
17:01
free stock charts from uk.advfn.com A number of bullish signs/trend reversal signs - highlighted in the text box areas.
multibagger
19/5/2019
10:20
Did you know LiDCO had its own dedicated USA website ? Here is the story behind it Building a new LiDCO website | Case Study Posted on August 10, 2017 By John Gregory hTtps://www.opencityinc.com/building-a-new-lidco-website-case-study/#.XOEo6MhKjIV Shane Doorish gets mentioned and was I'm sure instrumental in it happening. Looks like he did a great job with it via Opencity as the USA HUP orders have flown in ever since its creation If you have not seen it , its worth a look htTps://www.lidco.us/
buywell2
19/5/2019
10:13
multibagger Good one, so you are certified. LoL Yes the NHS has a lot of slack to take up , and we know why Hemodynamic Monitoring has been slowly building because the poor old NHS is cash strapped. This is why the LiDCO HUP model is working there also at long last, and evidence/data from the increasing numbers of patients that are now going to use LiDCO Hemodynamic Monitoring will speak for itself and encourage more NHS Trusts to follow suit IMO. My understanding is that the monies to buy the equipment comes from the anaesthetists budget. Different parts of the same hospital pay for the equipment they use out of their allocated budget. Hence being an ICU / operating room / device Hemodynamic Monitors primarily are paid for by anaesthetists. Perhaps after the next election the NHS is going to receive a considerable cash injection as BIG promises will be made by ALL parties to do this. More NHS HUP deals to then follow IMO
buywell2
19/5/2019
09:17
Thanks buywell2 ! You are right there are some technical/charting signs popping up indicating a bullish move in the offing. The volumes and price activity seem to corroborate that as well. I shall post the chart and my take on it for what it is worth when I get some time. I actually did the "Hemodynamics: What's that all about ?" online course on the LID website and got a certificate (the course and questions were straightforward) ! Speaking to a Consultant Anaesthetist/Intensivist in the NHS, I formed the impression that the uptake of haemodynamic monitoring is not huge and limited to the London area and further south. Though there are some big NHS hospitals using it in Birmingham, Manchester, Wolverhampton, Newcastle (Teaching hospitals/University centres) etc.Apparently decisions regarding buying/implementing haemodynamic monitoring are predicated as to whether the current Consultants were exposed to that technology during their training period. So there could be a bigger market in the UK itself that remains unaddressed.
multibagger
19/5/2019
08:29
agreed -------------------------------------------------------------------- To any LiDCO advfn newbes looking at this thread for the first time -------------------------------------------------------------------- Hemodynamic Monitoring is all about the management of fluids given to patients that have had a serious hospital operation. It therefore plays an important role in the management of today's acutely ill patient. This recent blog from the LiDCO website goes some way in explaining how and why it is so important. Published on Thursday, March 28th, 2019 by Josh Mudie. FLUID – THE RIGHT AMOUNT AT THE RIGHT TIME htTp://www.lidco.com/fluid-the-right-amount-at-the-right-time/ buywell adds: The use of LiDCO Hemodynamic monitoring has clinically demonstrated significant reduced deaths , reduced return to hospitals AFTER being sent home , reduced complications and infections , and reduced length of stay in the hospital bed. This is why the BIG hospitals and Institutions like University/Teaching Hospitals in the USA are increasingly using it. It is better for the patient as every patient is different and therefore fluid management needs to be 'tailored' to fit the patients own unique requirement to achieve optimum results, as per the link above. Of course this means extra work for the hospital staff and extra expense for the hospital administrators BUT when weighed against the above benefits the evidence is now showing that Hospitals are now using Hemodynamic Monitoring more. The LiDCO HUP offering did the trick BIGTIME both in the USA and now in the UK also. Roughly from recent use of LiDCO Hemodynamic Monitoring using the High Usage Plan HUP can and has resulted in : DOUBLE THE NUMBER OF PATIENTS BEING ABLE TO RECEIVE LiDCO HEMODYNAMIC MONITORING THAN WITH THEIR PREVIOUS HEMODYNAMIC SUPPLIER FOR 50% OF THE PREVIOUS SUPPLIER'S COST With at least the same quality of performance or better than. This is why LiDCO is now doing circa 1 HUP deal a month in the USA and why the bigger UK NHS Hospitals are increasingly switching over to LiDCO HUP
buywell2
19/5/2019
08:22
We are part owners of a business, so "we" and "us" reflects our fractional stake in the LID business. No ambiguity there !
multibagger
19/5/2019
07:50
IMO probably not ... but one or two here thought City Financial still was selling I do not as I have said before ... they are history ... done. I think Quilter must now be down to between 1% to 2% I also think CEO Matt Sassone will have probably spoke to them regarding the recent AGM Statement ... hence I think they might desist. The turnaround evidence is too big not to listen to. Would be very interesting if they now decided to build again. Your we and us references might want to be edited methinks as they are somewhat ambiguous
buywell2
19/5/2019
07:19
Good morning buywell2 ! Based on what you say and if things come to pass, we may see 8p by Christmas 2019. I agree that at the end of the year, we will be materially ahead of market expectations. China would be a key market as it would be greenfield for us effectively. Given we made our submission in Jan 19, it sounds like news (one way or the other) re regulatory clearance would be imminent, if processing timelines in China are adhered to. South Korea could be a another big market. South America has so many countries in it and I am not sure we would get a blanket approval there - it may be separate regulatory processes for each country unless they have the equivalent of an EU system. So apart from Quilter, are there any rumours of another big holder selling ?
multibagger
18/5/2019
12:43
Maybe But in the recent HUP update in march https://markets.ft.com/data/announce/detail?dockey=1323-13994817-4HKCQTK50QATQNS15O37VN3TPN LiDCO said '' further success in the USA contracting a large public university medical centre '' whereas this time they said '' the Board believes that this large institution has the potential to take many more monitors in the future '' the words hospital or university or medical centre NOT used IMO they would stick to the same terminology from one RNS to another. Either way it's good ... but my take is it could be something new. A 38% increase on last Q1 numbers, sets the tone for the rest of the year, and should I hope: 1. Stop the previous Institutional seller from selling more 2. Attract new Institutions into the stock at what is IMO a great entry point being circa 20% lower than the last time £3M cash was raised at 6p a share to fund the HUP USA initiative/sales strategy for growth. An initiative/sales strategy which is now paying off handsomely IMO and looks like continuing to do so. The numbers have looked bad to many for the last 2 years now From this point forwards IMO they will start to look better and better as the HUP recurring revenues add each year on top of the previous years. Also as a last point for any newbe reading this: 3. Matt Sassone the LiDCO CEO said in the broadcast (link top of header) that when LiDCO placed the Monitors and associated equipment at a new HUP location following a deal being signed, payback was achieved after 3 months. I think that is bloody good on 3 year and 5 year deals. dyor GLA
buywell2
17/5/2019
13:18
An "Institution" is likely to be a University linked teaching Hospital...that's my take on it.
multibagger
17/5/2019
10:13
I have just read that last post again And it just might be that the 'large Institution' mentioned is in fact NOT a hospital at all. There are several BIG Heath Service providers in the USA ie they provide services and equipment to USA Hospitals that use them. Health care in the United States is provided by many distinct organizations. Health care facilities are largely owned and operated by private sector businesses. 58% of US community hospitals are non-profit, 21% are government owned, and 21% are for-profit. If so this could turn out to be mega
buywell2
17/5/2019
10:01
Agreed USA and UK Newsflow about further HUP deals , something the market and many financial pundits never quite understood IMO , should now keep LiDCO on an upwards path. It is to be hoped that Quilter and any other Institution that has or might have been thinking of selling out of LiDCO will now have a rethink. Yes the wait and the road to profit has been long and arduous , but the corner has been turned and the finish line is in sight. LiDCO HUP is working and decent profitability for LiDCO will follow as recurring revenues from increased HUP uptake flows from the top line to the bottom line. BUT HUP was always designed to be a 'disruptive offering' that would encourage clients to switch from their existing Hemodynamic supplier to LiDCO. In the broadcast (link top of the header) , Matt Sassone CEO of LiDCO said he took Edwards lifesciences biggest single USA client , 1M per year, by offering LiDCO at 50% of that figure. The outcome was that the TOP Number One rated USA Cancer treatment Hospital switched to LiDCO and a year later are treating nearly TWICE as many patients using LiDCO Hemodynamic Monitoring equipment for HALF the price they were paying. If that is not a WIN/WIN I don't know what is. Needless to say this USA Hospital trialled the LiDCO product before they made the commitment to stop using Edwards lifesciences , and now are happy to speak to prospective LiDCO clients thinking of doing the same. Edwards can and will only lose so many such prestigious USA clients to LiDCO before it has to make a move. Whilst they are thinking about doing so … another company could beat them to it and make the move before them. In the AGM statement Matt Sassone said ''The Group has continued to make positive progress with the HUP offering, successfully implementing the three new accounts announced in March and closing an additional account in the US. Whilst the new account in the US has taken two monitors initially, the Board believes that this large institution has the potential to take many more monitors in the future. '' So there is yet another large institution trialling the LiDCO product … as they of course must , and as ALL big USA Hospitals will do … 'the Board believes that this large institution has the potential to take many more monitors in the future.' IMO there will be more to come at the rate of circa 1 a month this year Success breeds success and LiDCO has been getting ''excellent feedback'' hence 17/05/2019 07:35 Breakout Lidco hit an upwards 6 months price breakout.
buywell2
17/5/2019
09:19
China would be best as we do not want Lidco to be acquired at a rock bottom price.
sabre6
17/5/2019
08:10
sabre6 Yesterday around 2M LID shares were traded , just shy of 1% of the company, a few decent buys were made that suggest some investor/s believe that also LiDCO Group PLC LID Share Trades 16:30:42 4.95 250,000 0.00 0.00 ? 11:30:23 5.10 320,000 4.60 5.00 ? 10:28:13 4.95 162,628 4.60 5.00 ? IMO the next news will be regarding China approval or That LiDCO is being acquired dyor
buywell2
16/5/2019
16:48
Lidco had a share price of 9p just over a year ago. These figures announced today are a vast improvement so in theory it should not be long before we are back to 9p. Agree market has got it wrong.
sabre6
16/5/2019
15:01
If you listen to the broadcast in the link at the top of this thread header You will hear the LiDCO CEO Matt Sassone say he expects sales to start into China in the second half IMO turnover for the current full year will surprise the market to the UPSIDE when it comes in LiDCO will then get re-rated, 40% increase in turnover now in prospect IMO Lidco Makes Good Start To Year As 'High Usage Programme' Delivers LONDON 16th May, 2019 hTtp://www.morningstar.co.uk/uk/news/AN_1558000932130012400/lidco-makes-good-start-to-year-as-high-usage-programme-delivers.aspx
buywell2
16/5/2019
11:43
Excellent update and AGM to follow.Bacj to double figures!
smraynot
16/5/2019
07:11
GOOD NEWS LiDCO has made a good start to the year with Q1 revenues well ahead of Q1 last year and above the Board's expectations. LiDCO Group Plc AGM Statement 16/05/2019 Lidco (LSE:LID) Strong Q1 trading above Board's expectations LiDCO (AIM: LID), the hemodynamic monitoring company, will hold its Annual General Meeting today at 10am at the offices of finnCap, 60 New Broad Street, London, EC2M 1JJ. Ahead of that meeting, the Company provides an update of trading for the first quarter ended 30 April 2019 as follows: LiDCO has made a good start to the year with Q1 revenues well ahead of Q1 last year and above the Board's expectations. In the first quarter, LiDCO product revenues were up 38% versus prior year with like-for-like recurring revenues up 42%. Recurring revenues continue to benefit from the Group's unique, differentiated, High Usage Programme ('HUP') business model. At a geographical level, the US revenues, which the Board expect to be the main strategic driver of future growth, were up 69% in the quarter compared with Q1 last year. LiDCO UK revenues, excluding 3(rd) party products, were up 12% for the quarter. Outside of the two direct markets, distributor sales were up 84% for the quarter, benefiting from the timing of a number of European orders. The Group has continued to make positive progress with the HUP offering, successfully implementing the three new accounts announced in March and closing an additional account in the US. Whilst the new account in the US has taken two monitors initially, the Board believes that this large institution has the potential to take many more monitors in the future. Following excellent feedback, the Company is continuing to consolidate its market-leading position in the UK by converting its larger customers to HUP. In Q1, 19% of LiDCO's recurring revenues in the UK arose from HUP license income, up from 14% in the last financial year. As at 15 May, Group cash balances were in line with the Board's expectations and the Board believes that the Group remains firmly on track to deliver full year results in line with market expectations.
buywell2
10/5/2019
11:14
Gobbygnome is supposedly putting his money where his mouth is, must be big bucks at stake eh. Hahahahahaha. ---- prat
willib2
10/5/2019
09:18
Looks like big seller not quite finished....drip of sells with predictable impact on share price
multibagger
10/5/2019
08:22
Oops wrong thread
7767
08/5/2019
08:49
Interesting if correct hTtps://simplywall.st/news/who-are-the-major-shareholders-of-lidco-group-plc-aimlid/
buywell2
08/5/2019
08:08
Thanks buywell2 ! Anyone attending/intending LID AGM next week in London ? If I am in that neck of the woods, I'll try and attend.
multibagger
Chat Pages: 263  262  261  260  259  258  257  256  255  254  253  252  Older
Your Recent History
LSE
LID
Lidco
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190521 01:17:08